Company ProfilePremium

ABx Group Limited

Company Profile Analysis

Ticker: ABX.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
ABx Group Limited - Company showcase

Year Founded & Workforce

2009

ABx Group Limited logo

ABx Group Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

ABx Group Limited Overview

ABx Group is a Melbourne-headquartered, ASX-listed micro-cap. It has repositioned from a bauxite explorer-miner into a three-pillar critical-materials developer, with every asset in Australia.

Its lead asset is the Deep Leads ionic-adsorption-clay rare earth province in northern Tasmania. The JORC resource is 89 Mt. The company states its dysprosium-plus-terbium share of total rare earth oxides (4.3%) is the highest of any Australian clay-hosted deposit. A maiden mixed rare earth carbonate (MREC) has been produced and sampled by customers.

The second pillar is the 83%-owned ALCORE. It is commercialising a proprietary process that recovers hydrogen fluoride from surplus aluminium smelter "bath", with a continuous pilot plant under construction beside Rio Tinto's Bell Bay smelter.

The third pillar is a bauxite portfolio across Queensland, New South Wales and Tasmania. It is being monetised through a partnership with Good Importing International.

The company is pre-revenue (FY2025 mineral sales of A$115k) and funds itself through serial equity placements, grants and R&D tax offsets. Its auditor's report carries a material going-concern uncertainty.


Company's own description (paraphrased from AR FY2025, Review of Operations)

ABx describes itself as a uniquely positioned Australian company delivering materials "for a cleaner future." It names three current areas of focus:

  1. Heavy rare earths: supplying light and heavy rare earths from Tasmania into Western supply chains.

  2. Clean fluorine chemical production: producing industrial chemicals from an aluminium smelter by-product, through ALCORE.

  3. Near-term bauxite production: mining bauxite for the aluminium, cement and fertiliser industries.

The company also states that it follows best practice on agricultural land, aims to leave land better than it finds it, and only operates where it is welcomed.

Formally, the principal activities in FY2025 were rare earths and bauxite exploration in Queensland, NSW and Tasmania, plus R&D programs in NSW and Tasmania (AR FY2025, Directors' Report).

Independent characterisation

PillarStage (Oct 2026)Economic model once operatingValue-chain position
Deep Leads rare earths (Tas)Resource defined (89 Mt); maiden and second MREC produced at lab/bulk-sample scale with ANSTO; process-options studies done; scoping/economic studies in progressSale of MREC intermediate to rare earth separation plants (e.g., Ucore, Rare Earth Technologies) under offtakeUpstream: mining plus heap/tank leach plus precipitation to MREC; no separation or magnet making
ALCORE fluorine chemicals (Tas)Batch pilot proven; continuous pilot plant under construction at Bell Bay; installation early Q4 2026 to Q1 2027Takes smelter "bath" (about 50% fluorine) from aluminium smelters; sells anhydrous HF and, downstream, aluminium fluoride (AlF3) plus metal sulfate co-productsMidstream chemical processing; circular-economy recycling of an industrial by-product
Bauxite (Qld, NSW, Tas)Sunrise: approvals underway, funded by partner GII. DL130: mining lease granted, planning appeal in mediation. Taralga/Penrose: 100% ABx, GII option lapsed Aug 2026Direct-shipping-ore (DSO) bauxite sales for alumina refining (metallurgical grade), cement and fertiliserUpstream mining and haulage; port export (Bundaberg, Port Kembla) or domestic cement supply

ABx is best understood as a portfolio of three option-value development projects inside one listed shell. None of the three is yet producing.

Revenue model mix (FY2025 actual):

  • Product revenue (mineral sales): A$115k.

  • Non-operating income: A$1,873k, made up of R&D tax incentive A$824k, MMI grant income A$987k, other grants A$7k and interest A$55k.

  • Service, subscription and licensing revenue: none.

Prospectively, ALCORE could license its process to third-party smelters, but no licensing model has been publicly disclosed.

Customer types and end-markets (prospective):

  • Rare earth separation refiners outside China, serving permanent-magnet makers for EVs, wind turbines, robotics, electronics and defence.

  • Aluminium smelters as buyers of AlF3 and suppliers of bath feedstock.

  • HF consumers: fluorocarbons and refrigerants, fluoropolymers, semiconductors, solar cells and lithium-ion battery materials.

  • Alumina refineries, cement producers (e.g., Adelaide Brighton Cement's Birkenhead plant) and fertiliser producers for bauxite.

Strategy

Stated strategy themes (AR FY2025; AGM 26 May 2026)

LeverRare earths (Deep Leads)ALCORE
1Resource growth: explore the expanding northern-Tasmania tenement holdingPilot plant: build and run the continuous pilot to validate commercial design parameters
2Project design: economic studies supported by metallurgy (in-house, ANSTO, engineering partners)Project design: economic studies with international engineering partners
3Customer engagement: Ucore Rare Metals, Rare Earth Technologies and othersCustomer engagement: Australian and international customers

ABx frames itself as delivering materials for a cleaner future through three priority projects. For both rare earths and ALCORE, management names the same three levers to reach commercial production "as soon as possible":

For bauxite, the stated strategy is to selectively produce metallurgical-, cement- and fertiliser-grade bauxite with a focus on profitability. It is executed through partner capital (GII) rather than ABx balance-sheet capital.

Initiative register (last 24 months)

DateInitiativeDetail / target
Sep 2024Ucore MOUFramework for Ucore to buy and potentially invest in the Tasmanian rare earths project
15 Jan 2025Bell Bay ATC leaseLeased from Rio Tinto at a reduced rate; supported by the Tasmanian Government
9 Apr 2025Pilot equipment orderedOleum plant, bath reactors, scrubbers, cooling tower
2 May 2025Resource upgrade to 89 MtDeep Leads–Rubble Mound plus Wind Break
Sep 2025Overseas R&D FindingAusIndustry approval covering 2024–2026 offshore R&D with BFluor Chemicals (South Africa) and international suppliers, including more than A$2M of pilot capex
12 Sep 2025GII bauxite partnershipUp to A$5.4M for 75% of ABX3 (Sunrise); option at A$4.8M for 75% of ABX2 (lapsed Aug 2026)
Late 2025Industry Growth Program applicationALCORE Commercialisation and Growth Grant. The AR states A$3.03M; Sep 2026 coverage cites "up to A$5M". In merit assessment; outcome expected before end-2026
2 Dec 2025Maiden MREC4.0% Dy, 0.7% Tb of TREO
11 Mar 2026CMCI CRC partnershipPartner in the Critical Metals for Critical Industries Cooperative Research Centre (A$53M federal funding)
11 Mar 2026TeraGlo quantum sensorA$2.4M Critical Technologies Challenge Program grant (with TeraGlo) for a quantum-enabled geometallurgy sensor for clay-hosted rare earths
27 Mar 2026ALCORE Environmental Effects ReportSubmitted to EPA Tasmania
2 Jul 2026ALCORE cost positioningOpex US$1,000–1,600/t HF; 30–60% operating margin vs fluorspar route
13 Jul 2026Pilot construction acceleratingMajor civil and electrical works; staged installation early Q4 2026 to Q1 2027, then cold commissioning
Sep 2026Deep Leads infill drillingTargeting optimum mining zones within the 89 Mt resource

Medium-term targets and guidance

ItemGuidance as at Nov 2025Mar 2026Jul 2026
ALCORE pilot equipment deliveryQ1 2026First delivery Apr 2026Ongoing
ALCORE commissioningQ2 2026 (operations Q3 2026)Late Q3 2026Installation early Q4 2026–Q1 2027; cold commissioning after
Sunrise Stage 1 completion12–24 months from Oct 20252,0272027 (approvals-dependent)

No financial guidance is given (no revenue, EBITDA or capex targets). Operational timing guidance has slipped repeatedly:

ESG commitments. No quantified emissions targets are disclosed. Sustainability claims are qualitative:

  • ALCORE's circular economy (recycling smelter waste and displacing imports).

  • Low-radioactivity rare earths (2 ppm U, 6 ppm Th).

  • Ambient-temperature leaching.

  • Proximity to grid hydropower.

Products & Services

ABx has no commercial product line yet. Its "portfolio" consists of development products and the projects that will supply them.

Rare earths pillar

ItemDescriptionKey specificationsTarget customerStatus / yearPricing
Maiden MRECMixed rare earth carbonate from Deep Leads ore, via leaching, impurity removal and precipitation (in-house and at ANSTO)4.0% Dy and 0.7% Tb as % of TREO; company says this is more than twice any peer MREC. Specific radioactivity met IAEA exemption criteria (ASX 2 Mar 2026)Rare earth separation refiners outside ChinaProduced 2025 (ASX 2 Dec 2025); samples sent to multiple prospective customers; first formal feedback "highly favourable" (ASX 20 Mar 2026)Not disclosed. Benchmark (Nov 2025, cited in AR) puts Dy oxide above US$200/kg and Tb oxide above US$900/kg DDP China; CIF Europe more than 3x Chinese domestic
Second MREC (column-leach liquor)MREC from ANSTO column leach tests on a 100 kg bulk sample, simulating heap leachHigher heavy rare earth proportion and fewer key impurities than the maiden MRECSameASX 16 Mar 2026—
Deep Leads–Rubble Mound / Wind Break resourceIonic-adsorption-clay rare earth deposits89 Mt JORC; 36 ppm Dy+Tb (Dy2O3+Tb4O7); Dy+Tb = 4.3% of TREO; 2 ppm U3O8 and 6 ppm ThO2. AR footnote classifies it as inferred, indicated and measured (exact split partly garbled in the extracted text)Feed for MREC plantResource dated 2 May 2025; infill drilling to identify optimum mining zones (Sep 2026)Not applicable
T8 and T30 discoveriesNew rare earth discoveries in EL27/2022 (Temple Bar) and EL28/2022 (Triangle Flats), southeast of LauncestonMany intercepts above 350 ppm TREO-CeO2 cut-offResource growthASX 20 Jan 2026Not applicable
Flowsheet optionsTank leach (ammonium sulfate slurry) versus heap leachColumn tests: above 80% TREO and above 70% Dy/Tb extraction at ambient temperature and pressureProject designASX 23 Jan 2026Not applicable

ALCORE fluorine chemicals pillar

ItemDescriptionKey specificationsTarget customerStatusPricing / cost
Anhydrous hydrogen fluoride (AHF)Recovered from aluminium smelter bath (about 50% F) using a proprietary sulfuric acid/oleum processBatch pilot achieved 97% fluorine recovery (AR FY2024, released Mar 2025)Fluorochemical, semiconductor, solar and battery-material producers; Australia has imported 100% of AHF since 1995 (ASX 2 Jul 2026)Continuous pilot under construction at Bell BayIndicative opex US$1,000–1,600/t (lowest cost quartile) and 30–60% operating margin, per company (ASX 2 Jul 2026)
Aluminium fluoride (AlF3)HF combined with aluminium hydroxide using an existing commercial processEssential smelting chemical; Australian smelters import 100%, typically more than 80% from ChinaAustralian and overseas aluminium smeltersPlanned for a commercial plant at Bell Bay—
Metal sulfate co-productsSulfates from the bath reactionCould be sold as one chemical or refined into several; options under assessmentIndustrial chemical buyersUnder assessment—
Bath recycling service (implicit)Outlet for smelter surplus bath that would otherwise be stored or landfilledGlobal bath market expected to be in growing surplusGlobal aluminium majorsConceptual—

Bauxite pillar

ProjectProductResourceLogisticsStatus
Sunrise (Binjour, Qld) – ABX3, 30%Gibbsite-type metallurgical DSO bauxite37.0 Mt (14.2 Mt inferred, 22.8 Mt indicated)Export via Bundaberg portStage 1 (A$2.7M GII) funds mine planning and environmental/port approvals for at least 800,000 t DSO; Stage 1 completion expected 2027
DL130 (Tas) – 100%Cement-grade bauxiteNot restated in AR FY2025Road to port; ABCL Birkenhead, SAML 2142P/M granted to 2045; quarrying awaits resolution of TASCAT planning appeal (mediation continuing)
Taralga (NSW) – 100%Gibbsite-type metallurgical bauxite37.9 Mt (17.5 inferred, 20.4 indicated)About 200 km to Port KemblaGII option lapsed 17 Aug 2026; GII due-diligence study (environmental approvals, transport, port) completed
Penrose (NSW) – 100%Refractory-grade bauxiteNo JORC resourceAbout 90 km to Port Kembla, beside Hume HighwayDiscovery stage

Financial Narrative

All figures are A$'000, fiscal years ending 31 December. FY2021–FY2025 earnings come from the five-year summary in AR FY2025 (Remuneration Report, "Additional information"). FY2021–FY2023 cash flow figures come from aggregator data (Kalkine/TradingView). FY2024–FY2025 figures were verified against AR FY2025.

Income statement — 5-year

Source notes: FY2021–FY2023 revenue from TipRanks (aggregator). FY2024 matches AR FY2025 Note 6. Total income and losses are from the AR FY2025 five-year table.

Derived profitability metrics (analyst calculation)

EPS for FY2021–FY2023 is not publicly disclosed in the documents retrieved. Market Index shows trailing EPS of −A$0.024 and book value per share of A$0.028.

Margins. Gross, operating, EBITDA and net margins are not meaningful. Revenue (A$115k) is a tiny fraction of the cost base. The FY2025 net loss was about 56 times revenue.

Revenue CAGR FY2021–FY2025. Arithmetically 29.4% (A$41k to A$115k), but not meaningful as an indicator of business growth.

Commentary. The jump in the FY2025 loss (A$6.47M vs A$2.03M) is mostly non-cash:

  • A$3.873M accounting loss on deconsolidating ABX3. Sunrise bauxite capitalised exploration was derecognised and the retained 30% was booked at a fair value of A$1.157M.

  • A$1.130M impairment of exploration assets.

Excluding these items, the underlying cash-type loss widened only modestly. Administrative, development and exploration expenses rose 6%, with R&D spend up 14% to A$1.052M and corporate/admin up 23% to A$1.520M. Staff costs fell from A$730k to A$454k, probably reflecting capitalisation to ALCORE and exploration. New finance costs (A$294k) relate to the convertible notes. Grant and R&D income stayed a material offset (A$1.8M). Its composition shifted toward MMI grant drawdown, which has now ended because the unspent MMI funds were repaid.

Balance sheet (AR FY2025)

Commentary. Year-end FY2025 liquidity looked better than at any point since FY2021, after A$8.1M of share placements and A$1.475M of convertible notes. Receivables include a A$1.416M advance for pilot plant equipment.

Capitalised exploration fell A$4.46M, driven by the ABX3 deconsolidation and impairment. Equity rose only A$1.5M despite about A$9.6M of gross capital raised, a sign of heavy loss absorption.

The convertible notes (face value A$1 each) mature on 31 December 2026 and are classified as current. They are a near-term refinancing or conversion item.

Non-current "other liabilities" of A$1.988M are unchanged year-on-year. The extracted note detail was truncated, so their nature is not described here.

Cash flow

FY2021–FY2023 are aggregator data. FY2025 free cash flow is calculated as operating cash flow less A$1,793k of exploration payments.

Ratios (analyst calculation from AR FY2025)

Burn and runway. FY2025 combined operating and investing cash outflow was A$5.98M (going-concern note). Year-end cash was A$3.9M, with a further A$0.92M raised in March 2026. The auditor-acknowledged material uncertainty therefore reflects roughly 9–12 months of runway at the time of signing, before the A$4.1M September 2026 raise and about A$0.6M of FY2025 R&D refunds received in September 2026.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Economic Unit Details

Economic unitLegal vehicleABx interestContents

Rare earths

ABX4 Pty Ltd

100%

Deep Leads–Rubble Mound, Wind Break, T8, T30 and other ELs in northern Tasmania

Fluorine chemicals

ALCORE Limited

83%

ALCORE process IP, Bell Bay ATC lease, continuous pilot plant

Bauxite – Tasmania

ABX4 Pty Ltd

100%

DL130 project (ML 2142P/M), cement-grade supply to Adelaide Brighton Cement

Bauxite – Queensland

ABX3 Pty Ltd

30% (associate)

Sunrise project: Binjour 37.0 Mt; Bundaberg port DSO program

Bauxite – NSW

ABX2 Pty Ltd

100%

Taralga (37.9 Mt) and Penrose refractory-grade discovery

Income line (AUD K)

Income line (AUD K)FY2024FY2025

Sale of mineral (bauxite)

58115

R&D tax incentives

911824

MMI grant income (ALCORE)

551987

Other grants

1027

Other income (payable write-back)

8490

Interest income

16755

Total income

2,6381,988

Income Statement

Metric (AUD K)FY2021FY2022FY2023FY2024FY2025

Revenue – sale of mineral

415622258115

Total income (revenue + other income + interest)

5561,8001,6852,6381,988

Loss before income tax

-5,868-3,573-1,799-2,029-6,467

Income tax expense

00000

Loss after income tax

-5,868-3,573-1,799-2,029-6,467

Income Statement (FY2024–FY2025)

Line item (AUD K)FY2024FY2025

Revenue

58115

Interest income

16755

Other income

2,4131,818

Administrative, development and exploration expenses

-2,884-3,058

Depreciation and amortisation

-83-43

Impairment of exploration assets

-1,700-1,130

Loss on loss of control of subsidiary (ABX3)

0-3,873

Share of loss of associate

0-10

Fair value change in derivative liability

0-47

Finance costs

0-294

Loss before tax

-2,029-6,467

Loss attributable to owners of ABX Group

-2,002-6,471

Loss attributable to non-controlling interest

-274

Income Statement (2)

Metric (AUD K)FY2024FY2025

Gross profit (no cost of sales disclosed; equals revenue)

58115

Operating loss (loss before tax + finance costs − interest income)

-2,196-6,228

EBITDA (operating loss + D&A; impairment and deconsolidation loss included)

-2,113-6,185

EBITDA excluding impairment and ABX3 deconsolidation loss

-413-1,182

Net loss attributable to owners

-2,002-6,471

Per-share (A$ cents)

Per-share (A$ cents)FY2024FY2025

EPS basic

-0.80-2.40

EPS diluted

-0.80-2.40

Dividends per share

00

Balance Sheet

Metric (AUD K)FY2024FY2025

Cash and cash equivalents

5613,906

Restricted cash (MMI grant trust)

2,9742,650

Trade and other receivables

1841,857

Total current assets

3,9928,479

Mining tenements (capitalised E&E)

15,45510,997

Investment in associate (ABX3)

01,147

Total assets

19,53620,656

Contract liabilities (grant funds received in advance)

4,9742,720

Borrowings (convertible notes, current)

3701,833

Long-term debt

00

Total current liabilities

6,2015,831

Total liabilities

8,3117,934

Total equity

11,22512,722

Goodwill and intangibles (excl. E&E)

00

Working capital (current assets − current liabilities)

-2,2092,648

Net debt (borrowings − cash; negative = net cash)

-191-2,073

Key Financials

Metric (AUD K)FY2021FY2022FY2023FY2024FY2025

Cash incl. restricted (aggregator)

6,0902,0601,9907206,560

Cash Flow

Metric (AUD K)FY2021FY2022FY2023FY2024FY2025

Operating cash flow

-2,816-4,8825,040-668-2,115

Financing cash flow

7,59001,3108929,327

Free cash flow (aggregator definition)

-2,907-4,9862,540-2,608-3,908

FY2025 cash flow detail (AR FY2025)

FY2025 cash flow detail (AR FY2025)FY2024FY2025

Payments to suppliers and employees

-2,500-4,104

R&D tax incentives received

911824

Grant income received

653994

Payments for exploration and evaluation (capex proxy)

-1,940-1,793

Restricted cash movement (AR FY2025)

Restricted cash movement (AR FY2025)2000-2000

Proceeds from share issues

6168,125

Proceeds from convertible notes

3701,475

Share issue costs

-94-573

Dividends paid

00

Buybacks

00

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2024FY2025

ROE (%; loss ÷ average equity)

-16.9-54.0

ROA (%; loss ÷ average assets)

—-32.2

ROIC

Not meaningful (pre-revenue)

Not meaningful

Current ratio (x)

0.641.45

Debt / equity (x)

0.030.14

Net debt / EBITDA

Not meaningful (net cash, negative EBITDA)

Not meaningful

Interest coverage

Not applicable

Negative / not meaningful

Asset turnover (x; revenue ÷ average assets)

about 0.003

about 0.006

Region revenue (AUD K)

Region revenue (AUD K)FY2021FY2022FY2023FY2024FY2025

Australia

415622258115

Rest of world

00000

Share Price

MetricFY2021FY2022FY2023FY2024FY2025

Share price at 30 June (AUD)

0.0980.140.0980.0470.036

Share Price & Returns

DateMarket cap (AUD Mn)Source

Jun 2025

10.04

TipRanks

Sep 2025

19.39

TipRanks

1 Sep 2026

14.25

Discovery Alert

17 Sep 2026

14.62

Discovery Alert

Valuation Snapshot

MultipleValueComment

EV/Sales

About 90–110x

EV of about A$12–13M (market cap A$14.3M less about A$2M net cash at FY2025) ÷ A$115k revenue; not meaningful

P/B

About 1.1–1.2x

Market cap ÷ FY2025 equity of A$12.7M; ex-post dilution will change this

Capital Markets

ItemDetail

Analyst consensus

None. ABX is not covered by a major broker (Market Index). The company website links to "Analyst Coverage" (sponsored research is possible)

Dividend history and policy

No dividends ever paid; none expected

Credit ratings

None (Moody's, S&P and Fitch do not rate the company)

Debt maturity profile

Convertible notes (face value A$1.00 each) due 31 Dec 2026; FY2025 carrying value A$1.833M. No bank debt

Recent equity raises

A$3.0M at A$0.064 (Sep 2025); A$6.05M at A$0.081 (Nov 2025 / Mar 2026); A$4.1M at A$0.031 (Sep–Oct 2026; 1-for-2 options at A$0.046, 3 years)

Options overhang

79.7M options at the AR date (A$0.0576–A$0.1692), plus about 34M placement options and SPP/underwriter options pending EGM approval (29 Oct 2026)

Analyst Conclusions

Management guidance

ALCORE: pilot installation from early Q4 2026 to Q1 2027, then cold commissioning (ASX 13 Jul 2026). The IGP grant outcome is expected before end-2026.

Deep Leads: economic and scoping studies, infill drilling, and progressing offtake. No study date has been guided.

Sunrise: Stage 1 approvals completion expected in 2027.

DL130: quarrying awaits the TASCAT mediation outcome.

Financial guidance: none.

Consensus

Not available; there is no broker coverage.

Bull case

  1. Heavy rare earth scarcity premium. With Dy+Tb at 4.3% of TREO, an MREC carrying 4.0% Dy and 0.7% Tb, and ex-China prices more than 3x Chinese domestic levels, Deep Leads could command a basket price far above typical clay MRECs. A binding offtake or strategic equity investment (Ucore or others) could re-rate a roughly A$15M market cap sharply.

  2. ALCORE as a sovereign-capability play. Australia has imported 100% of its anhydrous HF since 1995. A bottom-quartile cost claim, Rio Tinto co-location and possible IGP funding together create a credible path to a first-of-a-kind plant. Successful continuous operation would validate a licensable process for global smelters with surplus bath.

  3. Non-dilutive and partner-funded value. GII funds Sunrise (30% free-carried to Stage 2). R&D offsets, grants and the A$300k option fee cut cash burn. Taralga returned at 100% keeps further bauxite optionality.

Bear case

  1. Funding treadmill. The FY2025 going-concern uncertainty, a raise at A$0.031 (less than half the A$0.064–0.081 prices of 2025), 80M+ options outstanding and convertible notes due 31 Dec 2026 all point to continued heavy dilution before any revenue.

  2. Execution slippage. ALCORE commissioning has moved about three quarters in eight months. Deep Leads has no published economics despite four years since discovery. Low absolute TREO grades leave project economics unproven.

  3. Thin governance and partner fragility. A three-person, executive-dominated board with no committees, the lapse of GII's NSW option, the unresolved DL130 appeal and pending EL renewals all add non-technical risk.

Catalysts and monitorables (next 12 months)

TimingCatalyst
23 Oct 2026SPP close (underwritten)
29 Oct 2026EGM approving options and SPP securities
30 Oct 2026September quarter Appendix 5B: cash runway
Q4 2026IGP grant decision (A$3.03M–A$5M)
Q4 2026Tasmanian EL renewals (Conara, Deloraine, Prossers Road)
Q4 2026–Q1 2027ALCORE pilot installation and cold commissioning; first HF samples to customers
31 Dec 2026Convertible note maturity: conversion versus cash repayment
Mar 2027FY2026 Annual Report: going-concern language
2026–2027Deep Leads scoping study; binding offtake or MOU conversion (Ucore, Rare Earth Technologies)
2,027Sunrise approvals; GII Stage 2 (A$2.7M to 75%)
OngoingDL130 TASCAT mediation outcome; first ABCL cement-grade shipments

Concluding analyst verdict

ABx Group is a high-risk, binary, early-stage critical-materials option. Its technical credentials outpace its financial capacity.

Over the past 18 months the company has done much of what a junior must to be taken seriously. It expanded the Deep Leads resource to 89 Mt. It produced two MRECs whose dysprosium and terbium content stands out among Australian peers. It cleared a radioactivity hurdle that hampers many rare earth projects. It obtained supportive early customer feedback. In ALCORE it has a genuinely differentiated circular-economy chemical process, sited beside a Rio Tinto smelter, aimed at a market where Australia is fully import-dependent.

Against this, the financial picture is stark:

  • Revenue is immaterial (A$115k in FY2025).

  • The FY2025 loss of A$6.5M was inflated by non-cash items but sits on a real cash burn of about A$6M a year (operating plus investing).

  • The auditor flagged material going-concern uncertainty.

  • The equity has been repriced sharply. The September 2026 raise at A$0.031 implies the market is unconvinced that technical progress has removed financing risk.

  • ALCORE timelines have slipped repeatedly.

  • The bauxite pillar, once the core business, is now partly owned by a partner, with GII declining to extend into NSW.

The investment case rests on two near-term proofs. First, continuous operation of the ALCORE pilot producing on-spec HF in H1 2027. Second, conversion of rare earth customer interest into a binding offtake or strategic equity, which would anchor a scoping study.

Success on either could re-rate a company valued at about A$15M, especially given geopolitical tailwinds in heavy rare earths and the existence of non-dilutive funding channels. Failure or further delay would most likely mean continued sub-scale placements and option-driven dilution.

On balance, ABX suits only speculative, risk-tolerant capital that understands micro-cap funding dynamics. Monitoring should focus on the quarterly Appendix 5B cash balance, the IGP decision, the convertible note settlement and ALCORE commissioning dates as the clearest indicators of whether the strategy is converging toward commercial value.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenureBackgroundEducation

Joycelyn Morton

Non-Executive Chair

Director since 3 Apr 2024; Chair since 30 Sep 2024

Senior roles at Shell Australia, Shell International and Woolworths; former CPA Australia National President; former NED of ASC Pty Ltd, Snowy Hydro and Argo Investments; chairs audit/risk committees including at Infrastructure NSW. Current boards: Gelion Plc (AIM), Felix Group Holdings (ASX: FLX), SEC Victoria

FCPA (Fellow and Life Member)

Dr Mark Cooksey

Managing Director and CEO

Since 1 Feb 2022

25+ years in process development at Rio Tinto/Comalco (Gladstone and NZ smelters), GE and CSIRO (about 16 years, including Senior Principal Research Leader)

PhD Chemical & Materials Engineering (Auckland); BE Materials (First Class Hons) and BSc (UWA)

Ian Levy

Executive Director (exploration; services via Justevian Pty Ltd)

Long-serving director, formerly MD; current service agreement since 1 Feb 2022

40+ years in mine development; WMC, Pancontinental, Gympie Gold; ex-CEO Allegiance Mining; 11 years on JORC (4 as Vice-Chair); former Federal President, Australian Institute of Geoscientists

Geologist

Mathew Watkins

Company Secretary

—

Chartered Accountant, Vistra Australia

CA

“—” = not publicly disclosed.

Directors' Remuneration

NameSalary/feesSuperLong service leaveShare-basedTotal FY2025Total FY2024

Joycelyn Morton

123,5839,40008,102141,08584,213

Dr Mark Cooksey

280,00032,9005,61412,490331,004323,850

Ian Levy

214,6435,35706,245226,245223,132

Total KMP

618,22647,6575,61426,837698,334731,221

Board & Management Changes

DateChange

1 Feb 2022

Mark Cooksey appointed MD and CEO

2 Apr 2024

Kenneth Boundy resigns as NED

3 Apr 2024

Joycelyn Morton appointed NED

30 Sep 2024

Paul Lennon resigns as Chair; Morton becomes Chair

2025

ALCORE appoints a Site Operations Manager

Q1 2026

Two Senior Process Engineers hired at ALCORE

Major Shareholders

RankHolderShares%
1

BNP Paribas Nominees <IB Au Noms Retailclient>

18,072,1064.83
2

Citicorp Nominees

13,084,8493.50
3

Mr P & Mrs C Palan <Napla Provident Fund>

9,505,0002.54
4

Aftron Pty Ltd <C E Vrisakis Family>

7,350,0001.96
5

Justevian Pty Ltd <Super Fund> (Ian Levy related)

7,216,8501.93
6

Yarraandoo Pty Ltd <Super Fund>

7,192,5001.92
7

BNP Paribas Noms Pty Ltd

6,535,2381.75
8

Whale Watch Holdings Ltd

6,000,0001.60
9

J P Morgan Nominees Australia

5,847,3091.56
10

Mr Louis Ghirardello

4,353,4211.16

Competitive Landscape

Key Competitors

CompetitorListingAsset / positioning vs ABx

Lynas Rare Earths

ASX: LYC

Only scaled non-China producer of separated rare earths; a potential MREC customer rather than a direct rival

Iluka Resources

ASX: ILU

Eneabba refinery under construction; heavy rare earth separation; potential customer

Arafura Rare Earths

ASX: ARU

Nolans hard-rock NdPr project; light rare earth focus

Ionic Rare Earths

ASX: IXR

Ionic clay project in Uganda (Makuutu) plus recycling in Belfast; closest model peer

Australian Rare Earths

ASX: AR3

Koppamurra ionic clay project (SA/Vic); Australian ionic-clay peer

Meteoric Resources

ASX: MEI

Caldeira ionic clay project (Brazil); larger resource, lower Dy/Tb share

Brazilian Rare Earths

ASX: BRE

Rocha da Rocha, high-grade Brazilian rare earths

Victory Metals

ASX: VTM

North Stanmore clay heavy rare earths (WA)

Aclara Resources

TSX: ARA

Ionic clay heavy rare earth projects in Chile and Brazil; separation in the US

Serra Verde

Private

Producing ionic clay rare earths in Brazil

Chinese and Myanmar ionic clay producers

Various

Dominant global source of heavy rare earths

Key Competitors — Orbia (Koura) – Mexico

CompetitorPositioning

Orbia (Koura) – Mexico

Integrated fluorspar-to-HF/AlF3 producer

Do-Fluoride New Materials – China

Major AlF3 and HF supplier

Fluorsid – Italy

AlF3 for smelters

Gulf Fluor – UAE

HF/AlF3 serving Gulf smelters

Chinese fluorspar-based AlF3 exporters

Supply more than 80% of Australian AlF3 imports (AR FY2025)

Peer Comparison FY2025

MetricABx Group FY2025Australian Rare Earths (AR3)Ionic Rare Earths (IXR)Meteoric Resources (MEI)

Revenue (AUD K)

115———

Revenue growth (%)

98———

Stage

Resource plus MREC produced

Resource / metallurgy

Resource plus recycling demo

Resource / PFS-stage

Recent Developments

At the time of retrieval (October 2026), Market Index displayed a "halted/suspended" flag on the ABX page. No corresponding announcement was located in this research pass, so the current trading status should be verified directly on the ASX.

Company Snapshot

$0.1M

Revenue

2009

Founded

Melbourne, Australia

Headquarters

SWOT Analysis

Strengths

  • Heavy-rare-earth-rich resource. Dy+Tb is 4.3% of TREO across 89 Mt, which the company says is the highest proportion of any Australian clay-hosted deposit (AR FY2025).
  • Product proof. The maiden MREC (4.0% Dy, 0.7% Tb) and an improved second MREC were produced with ANSTO; customer feedback was favourable (ASX 2 Dec 2025, 16 Mar 2026, 20 Mar 2026).
  • Benign metallurgy. Column leach achieved above 80% TREO and above 70% Dy/Tb extraction at ambient conditions, supporting a lower-capex heap leach (ASX 23 Jan 2026).
  • Low radioactivity. 2 ppm U3O8 and 6 ppm ThO2; MREC met IAEA exemption criteria (ASX 2 Mar 2026).
  • Blue-chip industrial backing for ALCORE. Rio Tinto lease at Bell Bay plus Tasmanian Government support (ASX 15 Jan 2025).
  • Claimed low-cost HF route. Indicative opex US$1,000–1,600/t, bottom quartile (ASX 2 Jul 2026).
  • Non-dilutive funding track record. A$5.68M MMI grant, about A$0.8–0.9M a year of R&D offsets, A$2.4M TeraGlo grant, and A$3.0M of GII cash (option fee plus Stage 1).

Weaknesses

  • Pre-revenue with persistent losses. FY2025 revenue A$115k against a loss of A$6.47M (AR FY2025).
  • Going-concern material uncertainty in the FY2025 accounts.
  • Heavy dilution. Placements at A$0.064 (Sep 2025), A$0.081 (Nov 2025) and A$0.031 (Sep 2026). About 79.7M options were outstanding at the AR date.
  • Repeated slippage of ALCORE commissioning. Guided Q2 2026 (Nov 2025), then late Q3 2026 (Mar 2026), then installation into Q1 2027 (Jul 2026).
  • Thin governance. Three-person board with two executives and no standing committees (AR FY2025).
  • Bauxite partner retreat. GII let the Taralga option lapse (17 Aug 2026). DL130 is still stuck in a TASCAT appeal.

Opportunities

  • Chinese heavy rare earth export restrictions widen the ex-China Dy/Tb premium (AR cites CIF Europe above 3x China domestic).
  • Converting the Ucore MOU and other customer talks into binding offtake or a strategic investment.
  • A pending IGP grant (A$3.03M per AR; up to A$5M per Sep 2026 coverage) decided before end-2026.
  • Province-scale growth: T8, T30 and pending ELs EL14/2025 and EL1/2026.
  • Licensing ALCORE to global smelters facing growing bath surpluses (AR FY2025 industry commentary).
  • Sunrise DSO cash flow (at least 800 kt) via the 30% ABX3 stake once approvals land (2027).

Threats

  • Rare earth price volatility and Chinese supply responses; dependence on a few Western refiners.
  • Equity-market access for micro-caps. Market Index shows ABX underperforming the ASX 200 by 57% over 1 year (Oct 2026 snapshot).
  • Scale-up risk: continuous-reactor behaviour may differ from batch results (AR risk factor 4).
  • Tenement renewals. Three Tasmanian ELs (Conara, Deloraine, Prossers Road) expire Sep–Dec 2026.
  • Planning and community opposition (DL130 appeal by a representor).
  • Convertible notes maturing on 31 Dec 2026 could force cash repayment or further dilution.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
9 Apr 2025All key ALCORE pilot equipment orderedPilot moves from design to procurement
Apr 2025MMI end-of-term report; A$2.78M repayableCash drain; DISR keen for the project to continue
22 Apr 2025639,657 shares issued for convertible note settlementMinor dilution
2 May 2025Rare earth resource increased to 89 MtAbout 70% larger than the 52 Mt estimate
26 May 2025AGM; director options approved; 98.89% remuneration voteGovernance
11 Jun 2025Further convertible notes issued (100,000)Funding
19 Jun 2025948,413 shares to Chair in lieu of feesCash conservation
Sep 2025AusIndustry Overseas R&D FindingWidens R&D refund base (more than A$2M pilot capex)
10–18 Sep 2025A$3.0M placement at A$0.064 (Tranche 1 A$2.9M)Funds Deep Leads studies
12 Sep 2025GII bauxite agreements signedMonetises bauxite without ABx capex
9 Oct 2025GII pays A$2.7M; owns 70% of ABX3Deconsolidation; A$3.87M accounting loss
15 Oct 2025Legacy equipment removed at Bell Bay ATCSite readiness
17 Nov 2025Tranche 2 placement plus 46.9M options at A$0.10Funding
24–25 Nov 2025A$6.05M placement at A$0.081Largest raise of the period
28 Nov 2025ALCORE pilot declared "fully funded"Commissioning then guided for Q2 2026
2 Dec 2025Maiden MREC (4.0% Dy, 0.7% Tb)Key technical de-risking
9 Dec 2025GII pays A$300k to extend Taralga option to 11 Jun 2026Non-dilutive cash
12 Dec 2025EL25/2022 grantedTenure growth
20 Jan 2026T8 and T30 rare earth discoveriesProvince-scale potential
23 Jan 2026Column leach above 80% TREO and above 70% Dy/TbSupports lower-capex heap leach
30 Jan 2026Dec 2025 quarterly reportCash inflows from equity and grants
2 Mar 2026EGM approves A$0.92M Tranche 2; MREC radioactivity exemption confirmedRemoves a key transport/handling hurdle
11 Mar 2026CMCI CRC partnership; A$2.4M TeraGlo sensor grantNon-dilutive R&D
16 Mar 2026Second MREC, higher heavy rare earths and lower impuritiesProduct quality
20 Mar 2026Favourable first formal customer feedback on MRECOfftake progress
27 Mar 2026ALCORE EER submitted to EPA Tasmania; commissioning reset to late Q3 2026First timing slip
30 Mar 2026FY2025 Annual Report; going-concern material uncertaintyFinancial risk flag
26 May 20262026 AGMStrategy reaffirmed; commissioning Q3 2026
4 Jun 2026Director options and Chair fee shares issuedGovernance
15 Jun 2026GII option extended to 11 Aug 2026; Sunrise approvals progressingBauxite
29 Jun 2026MMI repayment completed (A$2.61M total)Liability removed
2 Jul 2026ALCORE cost-advantage study (US$1,000–1,600/t opex)Commercial case
13 Jul 2026Pilot construction "accelerates"; installation early Q4 2026–Q1 2027Second timing slip
30 Jul 2026June 2026 quarterly report; cash decliningFunding pressure
17 Aug 2026GII Taralga option lapses; ABx retains 100%Mild negative; keeps optionality
1 Sep 2026Infill drilling within the 89 Mt resourceMine-planning input
14 Sep 2026About A$600k FY2025 R&D offsets received; IGP grant in merit assessmentNon-dilutive cash
17 Sep 2026A$4.1M raise at A$0.031 (18% discount); GII takes A$1.0MHeavy dilution, but strategic endorsement
28 Sep 2026SPP prospectus and EGM notice dispatchedProcess
Upcoming: 23 Oct 2026SPP closesUnderwritten by Alpine Capital
Upcoming: 29 Oct 2026EGM (options and SPP securities)Approval
Upcoming: 30 Oct 2026September quarter activities and cash flow reportCash and runway check

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Income Statement: Revenue & Gross Profit: Revenue rose from AUD 0.1 Mn in FY2024 to AUD 0.1 Mn in FY2025.
ABx Group Limited — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2024FY2025
Revenue0.10.1
Gross profit (no cost of sales disclosed; equals revenue)0.10.1

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. ABX Group Limited, Annual Report for the year ended 31 December 2025 (ASX, 30 Mar 2026) (announcements.asx.com.au)
  2. ABx Group, Annual Report FY2024 (ASX, 31 Mar 2025) (announcements.asx.com.au)
  3. ABx Group, Annual Report FY2023 (ASX, 28 Mar 2024) (announcements.asx.com.au)
  4. ABx Group, Annual Report FY2021 (ASX, 29 Apr 2022) (announcements.asx.com.au)
  5. ABx Group, Quarterly report Sep 2024 (ASX, 31 Oct 2024) (announcements.asx.com.au)
  6. ABx Group, AGM Materials (ASX, 26 May 2026) (announcements.asx.com.au)
  7. ABx Group, ALCORE Pilot Plant Construction Accelerates (13 Jul 2026) (bulletin.webull.com)
  8. ABx Group, ALCORE pilot fully funded (28 Nov 2025) (bulletin.webull.com)
  9. ABx Group, GII option extension (9 Dec 2025) (bulletin.webull.com)
  10. ABx Group, ABx retains 100% of Taralga and Penrose (17 Aug 2026) (bulletin.webull.com)
  11. ABx Group website announcements · abxgroup.com.au · abxgroup.com.au
  12. InvestSMART ASX announcement summaries (Jan–Jul 2026) (investsmart.com.au)
  13. Market Index ABX page (shareholders, director transactions, history) (marketindex.com.au)
  14. Discovery Alert, A$4.1M capital raise (17 Sep 2026) (discoveryalert.com)
  15. Discovery Alert, R&D refund and IGP grant (14 Sep 2026) (discoveryalert.com)
  16. Mining.com.au, ABx raises A$4.1M (17 Sep 2026) (mining.com.au)
  17. Green Review, ALCORE EER (27 Mar 2026) (greenreview.com.au)
  18. Morningstar AU profile (morningstar.com.au)
  19. TipRanks revenue history (tipranks.com)
  20. Kalkine company profile (5-year cash flow data) (kalkine.com)
  21. AL Circle, ALCORE incorporation (13 Sep 2018) (alcircle.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.